Tranzyme Pharma (TZYM), Norgine B.V. Say ULISES 008 Did Not Meet Endpoints in Second Phase 3
Go back to Tranzyme Pharma (TZYM), Norgine B.V. Say ULISES 008 Did Not Meet Endpoints in Second Phase 3| TRANZYME (NASDAQ: TZYM) | Delayed: 0.48 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.48 | 52 Week High | $5.16 | |||
| Open | $0.48 | 52 Week Low | $0.40 | |||
| Day High | $0.48 | P/E | N/A | |||
| Day Low | $0.48 | EPS | $-0.68 | |||
| Volume | 355,201 | |||||
